HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) All Versions of this Article: dc07-1569v1 31/5/995    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Goya Wannamethee, S Articles by Lowe, G. D. Search for Related Content PubMed PubMed Citation Articles by Goya Wannamethee, S Articles by Lowe, G. D. Social Bookmarking                What's this?

Tissue plasminogen activator, von Willebrand factor and risk of type 2 diabetes in older men

¹Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London NW3 2PF, UK
²Division of Cardiovascular and Medical Sciences, University of Glasgow, Royal Infirmary, Glasgow G31 2ER, UK
³Department of Community Health Sciences, St George's, University of London SW17 ORE, UK

goya{at}pcps.ucl.ac.uk

ABSTRACT

Abstract: Objective: To assess the relationship between putative markers of endothelial dysfunction (tissue plasminogen activator antigen, t-PA; and von Willebrand factor antigen, vWF) and development of type 2 diabetes; and the role of inflammation, adipokines, hepatic function and insulin resistance in modifying these relationships.

Research Design and Methods: Prospective study of 3562 non-diabetic men aged 60–79 followed up for an average 7 years during which there were 162 incident type 2 diabetes.

Results: Elevated t-PA (top third) was associated with a near three-fold increase in risk of diabetes compared to those in the bottom third after adjustment for lifestyle factors and waist circumference (relative risk, RR 2.98; 95%CI, 1.79–5.00; p<0.0001 for trend); weaker but significant (marginal) associations were seen with vWF (RR 1.24; 95%CI, 0.83-1.85; p=0.05 for trend). Both biomarkers of endothelial dysfunction correlated significantly with markers of inflammation (interleukin-6 (IL-6), C-reactive protein (CRP)), hepatic function (gamma-glutamyl transferase (GGT)), and insulin resistance; with t-PA showing stronger associations with adiposity, hepatic function and insulin resistance than vWF. T-PA was also significantly and inversely associated with adiponectin. Adjustment for IL-6, adiponectin and GGT attenuated the association of incident diabetes with vWF (RR 1.06; 95%CI, 0.71–1.60) but the relationship seen with t-PA remained significant [adjusted RR 2.19; 95%CI, 1.29–3.70). Subsequent adjustment for insulin attenuated the association further but t-PA was still associated with a significant increase in risk (adjusted RR 1.66; 95% CI 0.96–2.85); p=0.02 for trend).

Conclusion: T-PA antigen, but not vWF antigen, is independently associated with risk of type 2 diabetes.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?